SAR103168
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR103168, covering 2012-03-27 to 2012-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic Syndromes [Phase 1]